Abstract:Selectivity of natural agonists for their cognate receptors is one of the hallmarks of the members of GPCR family, and it is crucial for the specificity of downstream signal-transduction. However, this selectivity often breaks down in the chemokine receptor subfamily, wherein a high degree of promiscuity is observed with one receptor recognizing multiple chemokines and one chemokine binding to multiple receptors. The molecular determinants of such a striking promiscuity for natural ligands in the chemokine-chemokine receptor system remain mostly elusive and represent an important knowledge gap in our current understanding. Here, we carry out a comprehensive transducer-coupling analysis, testing all known C-X-C chemokines on every C-X-C type chemokine receptor, to generate a global fingerprint of the selectivity and promiscuity encoded within this system. Taking lead from our finding, we determined cryo-EM structures of the most promiscuous receptor, CXCR2, in complex with every interacting chemokine, and deciphered the conserved molecular signatures and distinct binding modalities. While most chemokines position themselves on the receptor as a dimer, CXCL6 exhibits a monomeric binding pose induced by a previously unanticipated reorientation of its carboxyl-terminal α-helix, leading to disruption of the dimer interface. Surprisingly, one of the chemokines, CXCL5, induces a ligand-swapped dimer of CXCR2, the first of its kind observed in class A GPCRs, wherein each protomer of the ligand engages its own receptor without any discernible receptor-receptor interface. These unique observations provide a possible structural mechanism for inherent functional specialization encoded in chemokines despite their convergence to a common receptor. Furthermore, we also determined cryo-EM structures of CXCR3 in complex with G-protein-biased and β-arrestin-biased small molecule agonists that elucidate distinct allosteric modulations in the receptor driving their divergent transducer-coupling bias. Guided by structural analysis and experimental validation, we discover that in contrast to previously held notion, small molecule agonists of CXCR3 display robust agonism at CXCR7, an intrinsically biased, β-arrestin-coupled receptor, making them first-in-class dual agonists for chemokine receptors with exclusive βarr-bias at CXCR7. Taken together, our study provides molecular insights into ligand promiscuity and signaling bias at the chemokine receptors, and also demonstrates a proof of principle that naturally encoded structural mimicry can be recapitulated using synthetic pharmacophores with potential implications for developing novel therapeutics.

Unveiling the structural mechanisms of nonpeptide ligand recognition and activation in human chemokine receptor CCR8

Cryo-EM structure and biochemical analysis of human chemokine receptor CCR8

Cryo-EM Structure and Biochemical Analysis of the Human Chemokine Receptor CCR8

Molecular Insights into Ligand Recognition and Activation of Chemokine Receptors CCR2 and CCR3

Structural basis of CXC chemokine receptor 2 activation and signalling

Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8

Structural insights into the activation of chemokine receptor CXCR2

Structural Basis for Chemokine Recognition and Receptor Activation of Chemokine Receptor CCR5.

Structural insights into the activation and inhibition of CXC chemokine receptor 3

Activation of the human chemokine receptor CX3CR1 regulated by cholesterol

Computational Studies of the Binding Modes of Ccr1 Antagonists

Identification and mechanism of G protein-biased ligands for chemokine receptor CCR1

Biophysical characterization of the CXC chemokine receptor 2 ligands

Molecular basis of ligand promiscuity, structural mimicry, and atypical dimerization in the chemokine receptors

Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5

Structural basis for CCR6 modulation by allosteric antagonists

Conformational Transitions and Activation of the Adhesion Receptor CD97.

Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.

Structural insights into CXCR4 modulation and oligomerization

Exploring the CXCR3 Chemokine Receptor with Small-Molecule Antagonists and Agonists

3D-Pharmacophere Models for CC Chemokine Receptor 1 Antagonists.